Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease: Validity of the SCOPA-Cog

V. Isella, C. Mapelli, N. Morielli, C. Siri, D. De Gaspari, G. Pezzoli, A. Antonini, M. Poletti, U. Bonuccelli, L. Picchi, A. Napolitano, M. Vista, I. M. Appollonio

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The detection of cognitive decline in Parkinson's disease (PD), at the Mild Cognitive Impairment (MCI) stage, has prognostic and treatment implications. The Movement Disorders Society (MDS) has recently published criteria and guidelines for the diagnosis of possible and probable PD-MCI. In the present study we assessed the ability of the Scales for Outcomes in Parkinson's disease-Cognition (SCOPA-Cog) to discriminate possible PD-MCI cases from patients with PD-dementia (PDD) and from cognitively intact PD subjects. Hundred-and-thirteen consecutive PD patients underwent the MMSE, the Dementia Rating Scale and an interview on independence in daily living, and were classified as cognitively intact (n=49), or as possible PD-MCI (n=33) or PDD (n=31), according to MDS criteria. Logistic regression analysis was carried out with PD-MCI diagnosis (yes/no) as an outcome variable, and age, education and the SCOPA-Cog total score as covariates. Classification of cases according to the regression model was used for constructing Receiver Operating Characteristic (ROC) curves. Area Under the Curve (AUC) was 0.92 [95% CI 0.86-0.98], for the differential diagnosis between PD-MCI and cognitively normal patients, and 0.97 [95% CI 0.80-1.00], for the differential diagnosis between PD-MCI and PDD. Sensitivity and specificity were 90% and 73% for the PD-MCI versus no cognitive impairment differentiation, at the cutpoint ≥24, and 93% and 97% for the PD-MCI versus PDD discrimination, at the cutpoint ≥17. The SCOPA-Cog is a quick and psychometrically sound PD-specific scale. Our findings support its use for the screening of possible PD-MCI.

Original languageEnglish
Pages (from-to)1160-1163
Number of pages4
JournalParkinsonism and Related Disorders
Volume19
Issue number12
DOIs
Publication statusPublished - Dec 2013

Fingerprint

Cognition
Parkinson Disease
Dementia
Cognitive Dysfunction
Movement Disorders
Differential Diagnosis
Aptitude
ROC Curve
Area Under Curve

Keywords

  • Dementia
  • Mild Cognitive Impairment
  • Parkinson's disease
  • SCOPA-Cog

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Clinical Neurology
  • Neurology

Cite this

Isella, V., Mapelli, C., Morielli, N., Siri, C., De Gaspari, D., Pezzoli, G., ... Appollonio, I. M. (2013). Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease: Validity of the SCOPA-Cog. Parkinsonism and Related Disorders, 19(12), 1160-1163. https://doi.org/10.1016/j.parkreldis.2013.08.008

Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease : Validity of the SCOPA-Cog. / Isella, V.; Mapelli, C.; Morielli, N.; Siri, C.; De Gaspari, D.; Pezzoli, G.; Antonini, A.; Poletti, M.; Bonuccelli, U.; Picchi, L.; Napolitano, A.; Vista, M.; Appollonio, I. M.

In: Parkinsonism and Related Disorders, Vol. 19, No. 12, 12.2013, p. 1160-1163.

Research output: Contribution to journalArticle

Isella, V, Mapelli, C, Morielli, N, Siri, C, De Gaspari, D, Pezzoli, G, Antonini, A, Poletti, M, Bonuccelli, U, Picchi, L, Napolitano, A, Vista, M & Appollonio, IM 2013, 'Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease: Validity of the SCOPA-Cog', Parkinsonism and Related Disorders, vol. 19, no. 12, pp. 1160-1163. https://doi.org/10.1016/j.parkreldis.2013.08.008
Isella, V. ; Mapelli, C. ; Morielli, N. ; Siri, C. ; De Gaspari, D. ; Pezzoli, G. ; Antonini, A. ; Poletti, M. ; Bonuccelli, U. ; Picchi, L. ; Napolitano, A. ; Vista, M. ; Appollonio, I. M. / Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease : Validity of the SCOPA-Cog. In: Parkinsonism and Related Disorders. 2013 ; Vol. 19, No. 12. pp. 1160-1163.
@article{330b6ed8cbe141888bb3d5a2456547df,
title = "Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease: Validity of the SCOPA-Cog",
abstract = "The detection of cognitive decline in Parkinson's disease (PD), at the Mild Cognitive Impairment (MCI) stage, has prognostic and treatment implications. The Movement Disorders Society (MDS) has recently published criteria and guidelines for the diagnosis of possible and probable PD-MCI. In the present study we assessed the ability of the Scales for Outcomes in Parkinson's disease-Cognition (SCOPA-Cog) to discriminate possible PD-MCI cases from patients with PD-dementia (PDD) and from cognitively intact PD subjects. Hundred-and-thirteen consecutive PD patients underwent the MMSE, the Dementia Rating Scale and an interview on independence in daily living, and were classified as cognitively intact (n=49), or as possible PD-MCI (n=33) or PDD (n=31), according to MDS criteria. Logistic regression analysis was carried out with PD-MCI diagnosis (yes/no) as an outcome variable, and age, education and the SCOPA-Cog total score as covariates. Classification of cases according to the regression model was used for constructing Receiver Operating Characteristic (ROC) curves. Area Under the Curve (AUC) was 0.92 [95{\%} CI 0.86-0.98], for the differential diagnosis between PD-MCI and cognitively normal patients, and 0.97 [95{\%} CI 0.80-1.00], for the differential diagnosis between PD-MCI and PDD. Sensitivity and specificity were 90{\%} and 73{\%} for the PD-MCI versus no cognitive impairment differentiation, at the cutpoint ≥24, and 93{\%} and 97{\%} for the PD-MCI versus PDD discrimination, at the cutpoint ≥17. The SCOPA-Cog is a quick and psychometrically sound PD-specific scale. Our findings support its use for the screening of possible PD-MCI.",
keywords = "Dementia, Mild Cognitive Impairment, Parkinson's disease, SCOPA-Cog",
author = "V. Isella and C. Mapelli and N. Morielli and C. Siri and {De Gaspari}, D. and G. Pezzoli and A. Antonini and M. Poletti and U. Bonuccelli and L. Picchi and A. Napolitano and M. Vista and Appollonio, {I. M.}",
year = "2013",
month = "12",
doi = "10.1016/j.parkreldis.2013.08.008",
language = "English",
volume = "19",
pages = "1160--1163",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier BV",
number = "12",

}

TY - JOUR

T1 - Diagnosis of possible Mild Cognitive Impairment in Parkinson's disease

T2 - Validity of the SCOPA-Cog

AU - Isella, V.

AU - Mapelli, C.

AU - Morielli, N.

AU - Siri, C.

AU - De Gaspari, D.

AU - Pezzoli, G.

AU - Antonini, A.

AU - Poletti, M.

AU - Bonuccelli, U.

AU - Picchi, L.

AU - Napolitano, A.

AU - Vista, M.

AU - Appollonio, I. M.

PY - 2013/12

Y1 - 2013/12

N2 - The detection of cognitive decline in Parkinson's disease (PD), at the Mild Cognitive Impairment (MCI) stage, has prognostic and treatment implications. The Movement Disorders Society (MDS) has recently published criteria and guidelines for the diagnosis of possible and probable PD-MCI. In the present study we assessed the ability of the Scales for Outcomes in Parkinson's disease-Cognition (SCOPA-Cog) to discriminate possible PD-MCI cases from patients with PD-dementia (PDD) and from cognitively intact PD subjects. Hundred-and-thirteen consecutive PD patients underwent the MMSE, the Dementia Rating Scale and an interview on independence in daily living, and were classified as cognitively intact (n=49), or as possible PD-MCI (n=33) or PDD (n=31), according to MDS criteria. Logistic regression analysis was carried out with PD-MCI diagnosis (yes/no) as an outcome variable, and age, education and the SCOPA-Cog total score as covariates. Classification of cases according to the regression model was used for constructing Receiver Operating Characteristic (ROC) curves. Area Under the Curve (AUC) was 0.92 [95% CI 0.86-0.98], for the differential diagnosis between PD-MCI and cognitively normal patients, and 0.97 [95% CI 0.80-1.00], for the differential diagnosis between PD-MCI and PDD. Sensitivity and specificity were 90% and 73% for the PD-MCI versus no cognitive impairment differentiation, at the cutpoint ≥24, and 93% and 97% for the PD-MCI versus PDD discrimination, at the cutpoint ≥17. The SCOPA-Cog is a quick and psychometrically sound PD-specific scale. Our findings support its use for the screening of possible PD-MCI.

AB - The detection of cognitive decline in Parkinson's disease (PD), at the Mild Cognitive Impairment (MCI) stage, has prognostic and treatment implications. The Movement Disorders Society (MDS) has recently published criteria and guidelines for the diagnosis of possible and probable PD-MCI. In the present study we assessed the ability of the Scales for Outcomes in Parkinson's disease-Cognition (SCOPA-Cog) to discriminate possible PD-MCI cases from patients with PD-dementia (PDD) and from cognitively intact PD subjects. Hundred-and-thirteen consecutive PD patients underwent the MMSE, the Dementia Rating Scale and an interview on independence in daily living, and were classified as cognitively intact (n=49), or as possible PD-MCI (n=33) or PDD (n=31), according to MDS criteria. Logistic regression analysis was carried out with PD-MCI diagnosis (yes/no) as an outcome variable, and age, education and the SCOPA-Cog total score as covariates. Classification of cases according to the regression model was used for constructing Receiver Operating Characteristic (ROC) curves. Area Under the Curve (AUC) was 0.92 [95% CI 0.86-0.98], for the differential diagnosis between PD-MCI and cognitively normal patients, and 0.97 [95% CI 0.80-1.00], for the differential diagnosis between PD-MCI and PDD. Sensitivity and specificity were 90% and 73% for the PD-MCI versus no cognitive impairment differentiation, at the cutpoint ≥24, and 93% and 97% for the PD-MCI versus PDD discrimination, at the cutpoint ≥17. The SCOPA-Cog is a quick and psychometrically sound PD-specific scale. Our findings support its use for the screening of possible PD-MCI.

KW - Dementia

KW - Mild Cognitive Impairment

KW - Parkinson's disease

KW - SCOPA-Cog

UR - http://www.scopus.com/inward/record.url?scp=84889098457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889098457&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2013.08.008

DO - 10.1016/j.parkreldis.2013.08.008

M3 - Article

C2 - 24011719

AN - SCOPUS:84889098457

VL - 19

SP - 1160

EP - 1163

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - 12

ER -